JFGIW
TRIB

Johnson Financial Group Inc (Wisconsin)’s Trinity Biotech TRIB Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-18
Closed -$2K – 726
2014
Q1 		$2K Buy
+18
New +$2.36K ﹤0.01% 687

Other funds holding TRIB

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return
CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s TRIB Position: Q2 2014 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Trinity Biotech (TRIB) in Q2 2014, closing a stake of 18 shares — an estimated $2K sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in TRIB in Q1 2014 and held it in 1 quarter. The position peaked at $2K in Q1 2014. 93 funds tracked by Wall St. Rank hold TRIB as of Q2 2014.

  • Johnson Financial Group Inc (Wisconsin) reported no remaining Trinity Biotech position as of Q2 2014 after selling out during the quarter.
  • Johnson Financial Group Inc (Wisconsin) sold 18 Trinity Biotech shares in Q2 2014, an estimated $2K.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Trinity Biotech in Q1 2014 and held it in 1 quarter.
  • Johnson Financial Group Inc (Wisconsin)'s Trinity Biotech position peaked at $2K in Q1 2014.
  • 93 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2014.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2014, filed 6 Aug 2014.